Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Rxsight Inc (RXST)

Rxsight Inc (RXST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
3 Growth Stocks to Grab for 29% Upside or More

These three promising growth stocks could deliver upside of 29% or more, according to analysts’ estimates.

ZS : 188.54 (-0.96%)
NTNX : 48.30 (+0.81%)
RXST : 46.77 (+1.59%)
NVDA : 117.93 (-2.61%)
$SPX : 5,505.00 (-0.71%)
AZPN : 191.71 (-0.62%)
Chart of the Day: RxSight - Cashing In On Cataracts

The Chart of the Day belongs to the ophthalmic devices company RxSight (RXST) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals,...

RXST : 46.77 (+1.59%)
RxSight, Inc. (RXST) Q2 2022 Earnings Call Transcript

RXST earnings call for the period ending June 30, 2022.

RXST : 46.77 (+1.59%)
RxSight, Inc. Files Shelf Registration Statement and Announces $50 Million At-The-Market Equity Offering Program

ALISO VIEJO, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to improving the...

RXST : 46.77 (+1.59%)
RxSight, Inc. Reports Second Quarter 2022 Financial Results

ALISO VIEJO, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to improving the...

RXST : 46.77 (+1.59%)
RxSight, Inc. to Report Second Quarter 2022 Financial Results on August 8, 2022

ALISO VIEJO, Calif., July 25, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to improving the...

RXST : 46.77 (+1.59%)
RxSight, Inc. (RXST) Q1 2022 Earnings Call Transcript

RXST earnings call for the period ending March 31, 2022.

RXST : 46.77 (+1.59%)
RxSight, Inc. to Present at the Bank of America Healthcare Conference

ALISO VIEJO, Calif., April 22, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to improving the...

RXST : 46.77 (+1.59%)
Surgeon Presentations to Highlight RxSight® Light Adjustable Lens System at Upcoming American Society of Cataract and Refractive Surgery Annual Meeting

ALISO VIEJO, Calif. , April 19, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to improving the...

RXST : 46.77 (+1.59%)
RxSight, Inc. to Present at the Needham Virtual Healthcare Conference

ALISO VIEJO, Calif., March 28, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to improving the...

RXST : 46.77 (+1.59%)

Barchart Exclusives

Grains: Watson and Occam’s Razor
Occam's razor tells us the simplest answer is usually closest to the truth. We need to keep this in mind as we look at the early rally in the Grains sector Monday morning. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar